• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌 RNA-Seq 技术对肥厚型心肌病的遗传学剖析

Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq.

机构信息

Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Institute of Animal Husbandry and Veterinary Science, Shanghai Academy of Agricultural Sciences, Shanghai 201106, China.

出版信息

Int J Mol Sci. 2020 Apr 25;21(9):3040. doi: 10.3390/ijms21093040.

DOI:10.3390/ijms21093040
PMID:32344918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7246737/
Abstract

Hypertrophic cardiomyopathy (HCM) is an inherited disorder of the myocardium, and pathogenic mutations in the sarcomere genes myosin heavy chain 7 () and myosin-binding protein C () explain 60%-70% of observed clinical cases. The heterogeneity of phenotypes observed in HCM patients, however, suggests that novel causative genes or genetic modifiers likely exist. Here, we systemically evaluated RNA-seq data from 28 HCM patients and nine healthy controls with pathogenic variant identification, differential expression analysis, and gene co-expression and protein-protein interaction network analyses. We identified 43 potential pathogenic variants in 19 genes in 24 HCM patients. Genes with more than one variant included the following: , , , , and . A total of 2538 protein-coding genes, six microRNAs (miRNAs), and 1617 long noncoding RNAs (lncRNAs) were identified differentially expressed between the groups, including several well-characterized cardiomyopathy-related genes (, , , , and ). Gene enrichment analysis revealed that those genes are significantly involved in heart development and physiology. Furthermore, we highlighted four subnetworks: mtDNA-subnetwork, DSP-subnetwork, MYH7-subnetwork, and MYBPC3-subnetwork, which could play significant roles in the progression of HCM. Our findings further illustrate that HCM is a complex disease, which results from mutations in multiple protein-coding genes, modulation by non-coding RNAs and perturbations in gene networks.

摘要

肥厚型心肌病(HCM)是一种心肌的遗传性疾病,肌球蛋白重链 7 () 和肌球蛋白结合蛋白 C () 的肌节基因突变解释了观察到的临床病例的 60%-70%。然而,HCM 患者表现出的表型异质性表明,可能存在新的致病基因或遗传修饰因子。在这里,我们通过对 28 名 HCM 患者和 9 名健康对照者的 RNA-seq 数据进行系统评估,包括致病变异识别、差异表达分析以及基因共表达和蛋白质-蛋白质相互作用网络分析。我们在 24 名 HCM 患者中确定了 19 个基因中的 43 个潜在致病变异。包含多个变异的基因包括: 、 、 、 、和 。共有 2538 个编码蛋白的基因、6 个 microRNAs (miRNAs) 和 1617 个长非编码 RNA (lncRNA) 在两组之间被鉴定为差异表达,其中包括一些特征明确的心肌病相关基因 ( 、 、 、 和 )。基因富集分析表明,这些基因显著参与了心脏发育和生理学。此外,我们突出了四个子网络:mtDNA 子网络、DSP 子网络、MYH7 子网络和 MYBPC3 子网络,它们可能在 HCM 的进展中发挥重要作用。我们的研究结果进一步表明,HCM 是一种复杂的疾病,它是由多个编码蛋白基因的突变、非编码 RNA 的调节以及基因网络的扰动所导致的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/8608721c895b/ijms-21-03040-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/9e38cc9f359f/ijms-21-03040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/061ede983055/ijms-21-03040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/654c291ab7cb/ijms-21-03040-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/22b25e4b0032/ijms-21-03040-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/2b72f8820f71/ijms-21-03040-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/b364ac3e17ea/ijms-21-03040-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/8608721c895b/ijms-21-03040-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/9e38cc9f359f/ijms-21-03040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/061ede983055/ijms-21-03040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/654c291ab7cb/ijms-21-03040-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/22b25e4b0032/ijms-21-03040-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/2b72f8820f71/ijms-21-03040-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/b364ac3e17ea/ijms-21-03040-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f95/7246737/8608721c895b/ijms-21-03040-g007.jpg

相似文献

1
Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq.心肌 RNA-Seq 技术对肥厚型心肌病的遗传学剖析
Int J Mol Sci. 2020 Apr 25;21(9):3040. doi: 10.3390/ijms21093040.
2
Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.MYH7、MYBPC3 和 TNNT2 变异与巴西肥厚型心肌病患者与心源性猝死相关危险因素的关联。
Forensic Sci Int Genet. 2021 May;52:102478. doi: 10.1016/j.fsigen.2021.102478. Epub 2021 Feb 3.
3
Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy.意大利肥厚型心肌病患者的β-肌球蛋白重链和心肌肌球蛋白结合蛋白基因突变率出人意料地低。
J Cell Physiol. 2011 Nov;226(11):2894-900. doi: 10.1002/jcp.22636.
4
Myocardial Deformation Analysis in and Related Sarcomeric Hypertrophic Cardiomyopathy-The Graz Hypertrophic Cardiomyopathy Registry.心肌变形分析与相关肌节肥厚型心肌病——格拉茨肥厚型心肌病注册研究。
Genes (Basel). 2021 Sep 23;12(10):1469. doi: 10.3390/genes12101469.
5
Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.肌节和线粒体相关多基因变异对肥厚型心肌病表型的差异贡献。
Mitochondrion. 2020 Jul;53:48-56. doi: 10.1016/j.mito.2020.04.010. Epub 2020 May 4.
6
Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.肥厚型心肌病的临床表型独立于基因突变和突变剂量。
PLoS One. 2017 Nov 9;12(11):e0187948. doi: 10.1371/journal.pone.0187948. eCollection 2017.
7
Circulating miR-499a-5p Is a Potential Biomarker of -Associated Hypertrophic Cardiomyopathy.循环 miR-499a-5p 是 - 相关肥厚型心肌病的潜在生物标志物。
Int J Mol Sci. 2022 Mar 30;23(7):3791. doi: 10.3390/ijms23073791.
8
Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.肥厚型心肌病临床表型的遗传决定因素。
BMC Cardiovasc Disord. 2020 Dec 9;20(1):516. doi: 10.1186/s12872-020-01807-4.
9
Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.肥厚型心肌病中与肌节突变相关的临床结局:对 7675 个人的荟萃分析。
Clin Res Cardiol. 2018 Jan;107(1):30-41. doi: 10.1007/s00392-017-1155-5. Epub 2017 Aug 24.
10
Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.心血管磁共振成像显示,MYH7(β-肌球蛋白重链)相关与MYBPC3(肌球蛋白结合蛋白C)相关的肥厚型心肌病在表型上无差异。
Circ Cardiovasc Imaging. 2017 Feb;10(2). doi: 10.1161/CIRCIMAGING.116.005311.

引用本文的文献

1
MicroRNA profiling of the feline left heart identifies chamber-specific expression signatures in health and in advanced hypertrophic cardiomyopathy.猫左心的微小RNA分析确定了健康和晚期肥厚型心肌病中特定腔室的表达特征。
J Mol Cell Cardiol Plus. 2023 Jun 2;4:100037. doi: 10.1016/j.jmccpl.2023.100037. eCollection 2023 Jun.
2
Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents Through In Silico Analysis and In Vitro Efficacy.通过计算机模拟分析和体外功效探索锦葵色素和紫锥菊宁作为潜在抗利什曼原虫药物的潜力。
Molecules. 2025 Jan 4;30(1):173. doi: 10.3390/molecules30010173.
3
Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?

本文引用的文献

1
Long non-coding and coding RNA profiling using strand-specific RNA-seq in human hypertrophic cardiomyopathy.使用 RNA 测序技术在人类肥厚型心肌病中进行长非编码 RNA 和编码 RNA 谱分析。
Sci Data. 2019 Jun 13;6(1):90. doi: 10.1038/s41597-019-0094-6.
2
Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction.血清 miR-23a、miR-30d 和 miR-146a 生物标志物在 ST 段抬高型心肌梗死中的价值。
Med Sci Monit. 2019 May 27;25:3925-3932. doi: 10.12659/MSM.913743.
3
Long Non-coding RNAs: At the Heart of Cardiac Dysfunction?
循环微小RNA作为肥厚型心肌病中有前景的生物标志物:先进的心脏磁共振能否为研究带来新见解?
Exp Biol Med (Maywood). 2024 Dec 18;249:10334. doi: 10.3389/ebm.2024.10334. eCollection 2024.
4
Transcriptomic and genetic profiling in a spontaneous non-human primate model of hypertrophic cardiomyopathy and sudden cardiac death.肥厚型心肌病和心源性猝死自发性非人灵长类动物模型中的转录组学和基因谱分析。
Sci Rep. 2024 Dec 28;14(1):31344. doi: 10.1038/s41598-024-82770-4.
5
Bidirectional Crosstalk between the Heart and Brain in Alzheimer's Disease.阿尔茨海默病中心脏与大脑之间的双向串扰
Aging Dis. 2024 Nov 5. doi: 10.14336/AD.2024.1132.
6
Unlocking the secrets of Cardiac development and function: the critical role of FHL2.揭开心脏发育与功能的秘密:FHL2的关键作用。
Mol Cell Biochem. 2025 Apr;480(4):2143-2157. doi: 10.1007/s11010-024-05142-6. Epub 2024 Oct 28.
7
Exploring Hypertrophic Cardiomyopathy Biomarkers through Integrated Bioinformatics Analysis: Uncovering Novel Diagnostic Candidates.通过综合生物信息学分析探索肥厚型心肌病生物标志物:发现新型诊断候选物
Cardiol Res Pract. 2024 Jul 4;2024:4639334. doi: 10.1155/2024/4639334. eCollection 2024.
8
Cardiac Development Long Non-Coding RNA () Is Activated during Human Heart Development and Contributes to Cardiac Specification and Homeostasis.心脏发育长链非编码 RNA () 在人类心脏发育过程中被激活,并有助于心脏特化和稳态。
Cells. 2024 Jun 18;13(12):1050. doi: 10.3390/cells13121050.
9
Integrative analysis of transcriptome, DNA methylome, and chromatin accessibility reveals candidate therapeutic targets in hypertrophic cardiomyopathy.转录组、DNA 甲基化组和染色质可及性的综合分析揭示了肥厚型心肌病的候选治疗靶点。
Protein Cell. 2024 Nov 1;15(11):796-817. doi: 10.1093/procel/pwae032.
10
Genome-wide enhancer-associated tandem repeats are expanded in cardiomyopathy.基因组广泛增强子相关串联重复序列在心肌病中扩张。
EBioMedicine. 2024 Mar;101:105027. doi: 10.1016/j.ebiom.2024.105027. Epub 2024 Feb 27.
长链非编码RNA:心脏功能障碍的核心所在?
Front Physiol. 2019 Jan 29;10:30. doi: 10.3389/fphys.2019.00030. eCollection 2019.
4
Hypertrophic cardiomyopathy mutations in dysregulate myosin.肥厚型心肌病突变会扰乱肌球蛋白。
Sci Transl Med. 2019 Jan 23;11(476). doi: 10.1126/scitranslmed.aat1199.
5
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.STRING v11:具有增强覆盖范围的蛋白质-蛋白质相互作用网络,支持在全基因组实验数据集的功能发现。
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.
6
fastp: an ultra-fast all-in-one FASTQ preprocessor.fastp:一个超快速的一体化 FASTQ 预处理程序。
Bioinformatics. 2018 Sep 1;34(17):i884-i890. doi: 10.1093/bioinformatics/bty560.
7
The genetics of hypertrophic cardiomyopathy.肥厚型心肌病的遗传学
Glob Cardiol Sci Pract. 2018 Aug 12;2018(3):36. doi: 10.21542/gcsp.2018.36.
8
Cardiac Fibrosis in Proteotoxic Cardiac Disease is Dependent Upon Myofibroblast TGF -β Signaling.心脏纤维化在蛋白毒性心脏疾病中依赖于肌成纤维细胞 TGF-β 信号通路。
J Am Heart Assoc. 2018 Oct 16;7(20):e010013. doi: 10.1161/JAHA.118.010013.
9
MiR-154 promotes myocardial fibrosis through β-catenin signaling pathway.miR-154 通过 β-连环蛋白信号通路促进心肌纤维化。
Eur Rev Med Pharmacol Sci. 2018 Apr;22(7):2052-2060. doi: 10.26355/eurrev_201804_14735.
10
Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias.肌联蛋白心肌病导致线粒体能量代谢异常、纤维化增加以及长期危及生命的心律失常。
Eur Heart J. 2018 Mar 7;39(10):864-873. doi: 10.1093/eurheartj/ehx808.